The University of Southern California (USC) Norris Comprehensive Cancer Center and Keck Medicine of USC have announced the appointment of oncologist and cancer researcher Steven Grossman, MD, PhD, as the center’s Cancer Physician in Chief. In this inaugural position, Dr. Grossman will provide executive leadership of oncology services, partnering with academic and clinical leaders to advance new models of multidisciplinary care delivery. He will also serve as Professor of Medicine at the Keck School of Medicine of USC.
“We are thrilled that Dr. Grossman will join us,” said Caryn Lerman, PhD, Director of the USC Norris Comprehensive Cancer Center and Associate Dean for Cancer Programs at the Keck School. “His exceptional experience and track record as a clinical and scientific leader will enable us to accelerate our mission of delivering the most innovative, evidence-based care to our diverse patient population.”
“I am truly honored to join USC Norris in this newly created position,” Dr. Grossman said. “I am excited to expand USC Norris’ exceptional patient-focused clinical cancer services, which provide multidisciplinary care and integrate cutting-edge clinical research at every level of the patient experience.”
Professional Background
Dr. Grossman, an expert in gastrointestinal cancers, is a past recipient of a Research Scholar Grant from the American Cancer Society, the Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research, and the Howard Temin Award in cancer research from the National Cancer Institute. He previously served as Deputy Director and Dianne Nunnally Hoppes Endowed Chair in Cancer Research at Virginia Commonwealth University Massey Cancer Center and as Chair of the Division of Hematology, Oncology, and Palliative Care.
Dr. Grossman received his undergraduate degree from Princeton University and his medical and doctoral degrees from the University of Chicago. He completed a residency in internal medicine at the Harvard Medical School–affiliated Brigham and Women’s Hospital and completed a fellowship in medical oncology and postdoctoral research training at the Dana-Farber Cancer Institute.
